Literature DB >> 34971747

Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review.

Elżbieta Cecerska-Heryć1, Aleksandra Polikowska2, Natalia Serwin2, Marta Roszak2, Bartłomiej Grygorcewicz2, Rafał Heryć3, Anna Michalczyk4, Barbara Dołęgowska2.   

Abstract

Oxidative stress is defined as the persistent imbalance between the activity of toxic reactive forms of both oxygen and nitrogen and the antioxidant defense. In low concentrations, they are essential for the proper functioning of the body. Still, their excessive amount contributes to the damage of the biomolecules, consequently leading to various pathologies of the organism. Due to the lipid-rich brain structure, enormous oxygen consumption, and the lack of a sufficient antioxidant barrier make it highly susceptible to oxidative imbalance. Hence, oxidative stress has been linked to various psychiatric disorders. These diseases include all behavioral, emotional, and cognitive abnormalities associated with a significant impediment to social life. Each of the diseases in question: Alzheimer's disease, schizophrenia, depression, and bipolar disorder, is characterized by excessive oxidative stress. Considerable damages to DNA, RNA, proteins, lipids, and mitochondrial dysfunction, are observed. All conditions show increased lipid peroxidation, which appears to be typical of psychiatric disorders because the brain contains large amounts of these types of molecules. In addition, numerous abnormalities in the antioxidant defense are noted, but the results of studies on the activity of antioxidant enzymes differ significantly. The most promising biomarkers seem to be GSH in Alzheimer's disease as an early-stage marker of the disease and thioredoxin in schizophrenia as a marker for therapy monitoring. Data from the literature are consistent with the decrease in antioxidants such as vitamin C, E, uric acid, albumin, etc. Despite these numerous inconsistencies, it seems that oxidative stress is present in the course of psychiatric diseases. Still, it cannot be conclusively determined whether it is the direct cause of development, a consequence of other abnormalities at the biochemical or molecular level, or the result of the disease itself.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Antioxidant defense; Bipolar disease; Depression; Oxidative stress; Schizophrenia

Mesh:

Substances:

Year:  2021        PMID: 34971747     DOI: 10.1016/j.neuint.2021.105269

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  3 in total

Review 1.  Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease.

Authors:  Qin Li; Limor Rubin; Marta Silva; Shuai Li; Chao Yang; Philip Lazarovici; Wenhua Zheng
Journal:  Oxid Med Cell Longev       Date:  2022-06-14       Impact factor: 7.310

Review 2.  The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders.

Authors:  Sarha A L Queiroz; Alyne M M Ton; Thiago M C Pereira; Bianca P Campagnaro; Larissa Martinelli; Aitor Picos; Manuel Campos-Toimil; Elisardo C Vasquez
Journal:  Front Psychiatry       Date:  2022-06-01       Impact factor: 5.435

3.  Antioxidant Properties of New Phenothiazine Derivatives.

Authors:  Olesya Voronova; Sergey Zhuravkov; Elena Korotkova; Anton Artamonov; Evgenii Plotnikov
Journal:  Antioxidants (Basel)       Date:  2022-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.